Tag Archives: Novartis AG

US-based cannabis sales are projected to reach US$75 billion in 2030 which will outpace the US$60B in wine sales of the $60 billion and almost match the US$77B in cigarette sales. This explosion in the cannabis market has caught the attention of big name brands hailing from other markets who can benefit from the integration of cannabis-based business. This article identifies 9 major consumer and pharmaceutical corporations who have bought into marijuana companies to take full advantage of this rapidly growing market.

Several biotechnology companies have had incredible success, both in the clinical setting and the real-world setting which has driven incredible investor interest, creating market opportunities that are hard not to watch. Today, we’ll review the top 5 companies that I believe to be presenting the strongest opportunities in the oncology space.